Thank you for joining us for today's conference call to discuss Tilray Brands' financial results for the second quarter ended ...

Reports Q2 net revenue $211M, consensus $216.33M. Irwin Simon, Chairman and CEO of Tilray (TLRY) Brands, stated, “In our fiscal second quarter, ...

Additionally, it reinforces Tilray’s commitment to deliver on Europe’s growing demand for premium medical cannabis products. Denise Faltischek, Chief Strategy Officer and Head of International ...

Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments. Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net ...

Additionally, it reinforces Tilray’s commitment to deliver on Europe’s growing demand for premium medical cannabis products. Denise Faltischek, Chief Strategy Officer ...

Shares of Tilray Brands Inc. TLRY slid 3.45% to $1.40 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.24% to ...

Additionally, it reinforces Tilray's commitment to deliver on Europe's growing demand for premium medical cannabis products. Denise Faltischek, Chief Strategy Officer and Head of International ...

In this article, we are going to take a look at where Tilray Brands, Inc. (NASDAQ:TLRY) stands against the other best long-term penny stocks to buy. On December 3rd, Bob Kaynor, CFA, Head of US ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.